Mariam E. Morris

2018

In 2018, Mariam E. Morris earned a total compensation of $687.5K as Former Chief Financial Officer at Avalo Therapeutics, a 116% increase compared to previous year.

Compensation breakdown

Option Awards$186,868
Salary$164,767
Other$335,833
Total$687,468

Morris received $335.8K in other compensation, accounting for 49% of the total pay in 2018.

Morris also received $186.9K in option awards and $164.8K in salary.

Rankings

In 2018, Mariam E. Morris' compensation ranked 10,793rd out of 14,244 executives tracked by ExecPay. In other words, Morris earned more than 24.2% of executives.

ClassificationRankingPercentile
All
10,793
out of 14,244
24th
Division
Manufacturing
4,349
out of 5,765
25th
Major group
Chemicals And Allied Products
1,641
out of 2,128
23rd
Industry group
Drugs
1,390
out of 1,817
24th
Industry
Pharmaceutical Preparations
1,067
out of 1,391
23rd
Source: SEC filing on June 19, 2019.

Morris' colleagues

We found six more compensation records of executives who worked with Mariam E. Morris at Avalo Therapeutics in 2018.

2018

Peter Greenleaf

Avalo Therapeutics

Chief Executive Officer

2018

Joseph Miller

Avalo Therapeutics

Chief Financial Officer

2018

James Harrell

Avalo Therapeutics

Executive Vice President, Marketing and External Communications

2018

Pericles Calias

Avalo Therapeutics

Chief Scientific Officer

2018

Robert Moscato

Avalo Therapeutics

Chief Operating Officer

2018

Simon Pedder

Avalo Therapeutics

Chairman

News

You may also like